Social Determinants of Health in Hepatobiliary Cancer Patients
ConditionMalignant Hepatobiliary Neoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
Eligibility criteria
Qualifiers
Patients 18+ year of age with hepatobiliary cancers
Disqualifiers
Patients under 18 years of age
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
400 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Source ClinicalTrials.gov